Skip to main content

Rezidivprophylaxe bipolarer Störungen: Aktuelle Aspekte

  • Conference paper
Depressionsstationen/Stationäre Depressionsbehandlung

Zusammenfassung

Das Wiederauftreten depressiver und manischer Episoden zu verhindern, ist nicht nur wegen der sozialen und ökonomischen, sondern auch wegen der familiären und insbesondere individuellen Konsequenzen für den einzelnen Patienten ein vordringliches Ziel.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Ahrens B (1995a) Suizidprävention and Langzeittherapie bei affektiven Störungen. In: Wolfersdorf M, Kaschka W P (Hrsg) Suizidalität - die biologische Dimension. Springer, Berlin Heidelberg New York, 175–191

    Google Scholar 

  • Ahrens B (1995b) Lithium treatment and suicide prevention in affective disorders. European Neuropsychopharmacology 5: 301

    Article  Google Scholar 

  • Ahrens B, Müller-Oerlinghausen B, Schou M et al. (1995) Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium-prophylaxis. Journal of Affective Disorders 33: 67–75

    Article  PubMed  CAS  Google Scholar 

  • Ahrens B, Linden M (1996) Is there a suicidality syndrome independet of specific major psychiatric disorder? Results of a split half multiple regression analysis. Acta Psychiatr Scand 94: 79–86

    Article  PubMed  CAS  Google Scholar 

  • Angst J (1986) The course of affective disorders. In: Latest findings on the aetiology and therapy of depression. Psychopathology (suppl 2) 19: 47–52

    Article  PubMed  Google Scholar 

  • Asberg M, Nordström P (1988) Biological correlates of suicidal behavior. In: Möller HJ, Schmidtke A, Welz R (eds) Current Issues of Suicidology. Springer, Berlin, pp 221–241

    Google Scholar 

  • Bauer M (1996) Adjuvante Schilddrüsenhormonbehandlung bei affektiven Psychosen. Psycho 22: 4: 288–290

    Google Scholar 

  • Bauer M (1994) Refractoriness induced by lithium discontinuation despite adequate serum lithium levels. Am J Psychiatry 151: 1522

    PubMed  CAS  Google Scholar 

  • Bauer M, Ahrens B (1996) Bipolar Disorder: A practical guide to drug treatment. CNS Drugs 6 (1): 35–52

    Article  CAS  Google Scholar 

  • Berghöfer A, Müller-Oerlinghausen B (1996) No loss of efficacy after discontinuation and reinstitution of long-term lithium treatment? In: Gallicchio V et al. (eds) Lithium: Biochemical and Clinical Advances. (in press)

    Google Scholar 

  • Brown GL, Goodwin FK, Ballenger JC, Goyer PF, Major LF (1979) Agression in humans correlates with cerebrospinal fluid amine metabolite. Psychiatr Res 1: 139

    Article  CAS  Google Scholar 

  • Cohen LS, Friedman JM, Jefferson et al.(1994) A reevaluation of risk of in utero exposure to lithium. JAMA; 271: 146–150

    Article  PubMed  CAS  Google Scholar 

  • Coppen A (1994) Depression as a Lethal Disease: Prevention Strategies. J Clin Psychiatry 55 (4, suppl): 37–45

    PubMed  Google Scholar 

  • Coppen A, Abou-Saleh MT, Milln P et al. (1983) Decreasing lithium dosage reduces morbidity and side effects during prophylaxis. J Affective Disord 5: 353–362

    Article  CAS  Google Scholar 

  • Coppen A, Standish-Barry H, Bailey J, Houston G, Silcocks P, Hermon C (1991) Does lithium reduce the mortality of recurrent mood disorders? J Affective Disord 23:1–7

    Article  CAS  Google Scholar 

  • Coxhead N, Silverstone T, Cookson J (1992) Carbamazepine versus lithium in the prophylaxis of bipolar affective disorder. Acta Psychiatr Scand; 85:114–118

    Article  PubMed  CAS  Google Scholar 

  • Dilling H, Mombour W, Schmidt M H (Hrsg) (1993) Internationale Klassifikation psychischer Störungen, ICD-10, Kapitel V (F). Klinisch-diagnostische Leitlinien (2. Auflage). Huber, Bern Gsttingen Toronto

    Google Scholar 

  • Fawcett J (1995) Compliance Definitions and Key Issues. J Clin Psychiatry (1995) 56, Suppl 1

    Google Scholar 

  • Goodwin F K, Jamison K R (1990) Manic-Depressive Illness. Oxford University Press, New York

    Google Scholar 

  • Greil W, Ludwig-Mayerhofer W, Czernik A et al. (1994) Lithium-oder Carbamazepinprophylaxe bei affektiven Psychosen? Ergebnisse einer kontrollierten, multizentrischen Studie. In: Müller-Oerlinghausen B, Berghöfer A (Hrsg) Ziele und Ergebnisse der medikamentösen Prophylaxe affektiver Psychosen. Thieme Verlag, Stuttgart New York, 113–119

    Google Scholar 

  • Grof P, Ahrens B, Yamamotova A et al. (1994) Chronobiologische Verlaufsmuster affektiver Erkrankungen. In: Müller-Oerlinghausen B, Berghöfer A (Hrsg). Ziele und Ergebnisse der medikamentösen Prophylaxe affektiver Psychosen. Thieme Verlag, Stuttgart New York, S 67–78

    Google Scholar 

  • Guze S B, Robins E (1970) Suicide in primary affective disorders. Br J Psychiatry 117: 437–338

    Article  PubMed  CAS  Google Scholar 

  • Källen AJB (1994) Maternal carbamazepine and infant spina bifida. Reprod Toxicol 8: 203–205

    Article  PubMed  Google Scholar 

  • Linnoila M, Virkkunen M, Scheinin M, Nuutila A, Rimon R, Goodwin FK (1983) Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sci 33: 2609

    Article  PubMed  CAS  Google Scholar 

  • McElroy SL, Keck PE Jr, Pope HG Jr et al. (1989) Valproate in psychiatric disorders: literature review and clinical guidelines. J Clin Psychiatry; 50 (3, Suppl): 23–29

    PubMed  Google Scholar 

  • Müller-Oerlinghausen B (1985) Lithium long-term treatment - does it act via serotonin? Pharmacopsychiatry 18: 214–217

    Article  PubMed  Google Scholar 

  • Müller-Oerlinghausen B, Ahrens B, Grof E et al. (1992a) The effect of long-term lithium treatment on the mortality of patients with manic-depressive and schizo-affective illness. Acta Psychiatr Scand 86: 218–222

    Article  Google Scholar 

  • Müller-Oerlinghausen B, Müser-Causemann B, Volk J (1992b) Suicides and parasuicides in a high-risk patient group on and off Lithium long-term medication J Affective Disord 25: 261–270

    Google Scholar 

  • Nilsson A (1994) Lithium und menschliche Aggression. In: Müller-Oerlinghausen B, Berghöfer A (Hrsg) Ziele und Ergebnisse der medikamentösen Prophylaxe affektiver Psychosen. Thieme Verlag, Stuttgart New York, S 27–33

    Google Scholar 

  • Nurnberg H G, Martin G A, Karajgi B M et al. (1994) Response to anticonvulsant substitution among refractory bipolar manic patients. J Clin Psychopharmacol 14: 207–208

    Article  PubMed  CAS  Google Scholar 

  • Omtzigt JGC, Los FJ, Grobbee DE et al. (1992) The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort. Neurology 42 (Suppl. 5):119–125

    PubMed  CAS  Google Scholar 

  • Post R M (1992) The transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 149: 999–1010

    PubMed  CAS  Google Scholar 

  • Post R M, Leverich G S, Altshuler L, Mikalauskas K (1992) Lithium -discontinuation induced refractoriness: preliminary observations. Am J Psychiatry 149; 1727–1729

    PubMed  CAS  Google Scholar 

  • Post RM, Leverich GS, Pazzaglia PJ et al. (1993) Lithium tolerance and discontinuation as pathways to refractoriness. In: Birch NJ Padgham C, Hughes MS (eds) Lithium in medicine and biology. Carnforth: Mareius Press, pp 71–84

    Google Scholar 

  • Quitkin FM, Kane J, Rifkin A et al. (1981) Prophylactic lithium carbonate with and without imipramine for bipolar 1 patients. Arch Gen Psychiatry 38: 902–907

    PubMed  CAS  Google Scholar 

  • Schou M (1984) Long-lasting neurological sequelae after lithium intoxication. Acta Psychiatr Scand 70: 594–602

    Article  PubMed  CAS  Google Scholar 

  • Schou M (1991) Relapse prevention in manic-depressive illness: Important and unimportant factors. Can J Psychiatry 36: 502–506

    PubMed  CAS  Google Scholar 

  • Schou M (1993) Lithium Treatment of Manic-Depressive Illness: A Practical Guide, 5th ed. S Karger, New York

    Google Scholar 

  • Schou M (1995) Is there a lithium withdrawal syndrome? An examination of the evidence. Brit J Psychiatry 163: 514–518.

    Article  Google Scholar 

  • Schumann C, Lenz G (1996) Zur Compliance bei Rezidivprophylaxe von affektiven Störungen. psycho 22, 4: 282–287

    Google Scholar 

  • Thies-Flechtner K, Seibert W, Walther A et al. (1994) Suizide bei rezidivprophylaktisch behandelten Patienten mit affektiven Psychosen. In: Müller-Oerlinghausen B, Berghöfer A (Hrsg) Ziele und Ergebnisse der medikamentösen Prophylaxe affektiver Psychosen. Thieme Verlag, Stuttgart New York, S 61–64

    Google Scholar 

  • Träskman L, Asberg M, Bertilsson L, Sjostrand L (1981) Monoamine metabolites in CSF and suicidal behavior. Arch Gen Psychiatry 38: 631–636

    PubMed  Google Scholar 

  • Valzelli L, Garattini S (1972) Biochemical and behavioural changes induced by isolation in rats. Neuropharmacology 11: 17

    Article  PubMed  CAS  Google Scholar 

  • Waters C H, Belai Y, Gott P S, et al. (1994) Outcomes of pregnancy associated with antiepileptic drugs. Arch Neurol 51: 250–253

    PubMed  CAS  Google Scholar 

  • Whybrow PC (1994) The therapeutic use of triiodothyronine and high dose thyroxine in psychiatric disorder. Acta med Austriaca 21: 47–52

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Ahrens, B. (1997). Rezidivprophylaxe bipolarer Störungen: Aktuelle Aspekte. In: Wolfersdorf, M. (eds) Depressionsstationen/Stationäre Depressionsbehandlung. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60807-0_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60807-0_17

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-62902-3

  • Online ISBN: 978-3-642-60807-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics